ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Stock Balance Sheet
NASDAQ:ADAP - Nasdaq - US00653A1079 - ADR - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 116.74M | 143.99M | 108.00M | 149.90M | 56.90M | |||
| Marketable Securities | 69.35M | 2.95M | 96.60M | 219.60M | 311.30M | |||
| Receivables | 38.61M | 46.92M | 38.10M | 34.00M | 20.70M | |||
| Inventories | 1.87M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 17.64M | 13.70M | 12.70M | 11.80M | 9.20M | |||
| Total Current Assets | 244.21M | 207.55M | 255.40M | 415.50M | 398.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 65.29M | 71.71M | 71.50M | 51.40M | 46.70M | |||
| Intangibles | 4.28M | 330.00K | 400.00K | 1.00M | 1.70M | |||
| Other Non-Current Assets | 3.65M | 3.03M | 1.60M | 1.70M | 4.60M | |||
| Total Non-Current Assets | 73.22M | 75.06M | 73.50M | 54.00M | 52.90M | |||
| TOTAL ASSETS | 317.44M | 282.62M | 328.90M | 469.50M | 451.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 34.51M | 35.64M | 31.80M | 31.90M | 29.80M | |||
| Accounts Payable | 9.07M | 8.13M | 4.80M | 8.10M | 6.40M | |||
| Other Current Liabilities | 19.88M | 29.02M | 28.00M | 22.50M | 2.90M | |||
| Total Current Liabilities | 63.46M | 72.79M | 64.50M | 62.50M | 39.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 49.87M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 124.13M | 170.31M | 182.50M | 201.00M | 70.80M | |||
| Total Non-Current Liabilities | 173.99M | 170.31M | 182.50M | 201.10M | 70.80M | |||
| TOTAL LIABILITIES | 237.45M | 243.10M | 247.00M | 263.60M | 109.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.02B | -1.02B | -909.30M | -743.80M | -585.80M | |||
| Additional Paid In Capital | 1.10B | 1.06B | 990.70M | 959.60M | 935.70M | |||
| Common Shares | 2.08M | 1.86M | 1.40M | 1.30M | 1.30M | |||
| Other Shareholders' Equity | -5.19M | -3.75M | 100.00K | -10.80M | -10.00M | |||
| Shares Outstanding | 255.82M | 227.27M | 164.59M | 156.32M | 154.87M | |||
| Tangible Book Value per Share | 0.05 | 0.03 | 0.08 | 0.22 | 0.37 | |||
| Total Shareholders' Equity | 79.99M | 39.51M | 81.90M | 206.00M | 341.20M | |||
| TOTAL LIABILITIES AND EQUITY | 317.44M | 282.62M | 328.90M | 469.50M | 451.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.62 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 3.85 | 2.85 | 3.96 | 6.65 | 10.18 | |||
| Return On Assets (ROA) | -14.02% | -40.29% | -50.31% | -33.67% | -28.84% | |||
| Return On Equity (ROE) | -55.65% | -288.19% | -202.03% | -76.74% | -38.13% | |||
All data in USD , ROIC based on taxRate of 0.21